• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sharps Technology, Inc. Announces over $400 Million Private Placement seeking to Establish the Largest Solana Digital Asset Treasury Strategy

    8/25/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care
    Get the next $STSS alert in real time by email

    Investors include leading financial institutions and digital asset market leaders such as ParaFi, Pantera, Monarq, FalconX, Phoenix Capital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, CoinFund, Arrington Capital, Quantstamp, CoinList Alpha, Primitive Ventures, Avenir, Hypersphere, and more

    NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced the pricing of a private placement offering to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Solana is the fastest and most used public blockchain in the world, processing more transactions and generating more onchain fee revenue than all other blockchains combined.

    Sharps Technology

    "Solana defines the standard for digital infrastructure, providing a high-throughput, low-cost, real-time settlement layer for everything from blue-chip equities to bonds to private assets," said Alice Zhang, the Company's newly appointed Chief Investment Officer and Board member. "Global adoption of Solana's ecosystem is accelerating as it continues to receive institutional support for its vision of a single global market for every tradeable asset, making now the right time to establish a digital asset treasury strategy with SOL. We will have a team with deep ties to the Solana ecosystem and proven founder-level experience in scaling institutional digital asset platforms, which we believe will set the Company up for success."

    "We believe our digital asset-native advisory team, defined accumulation strategy, and partnerships with top-tier asset managers position us well to become a leading SOL treasury," said Paul K. Danner, Executive Chairman of Sharps Technology.

    James Zhang, co-founder of Jambo and a well-known public figure in the Solana space with prior speaking engagements at Solana Breakpoint, Davos, Forbes, and more, will serve as strategic advisor and consultant to the Company. He will be working with top-tier asset managers including Monarq Asset Management, ParaFi, and Pantera to grow the digital asset treasury.

    "Solana is internet capital markets, the next evolution in global finance," said Mr. Zhang. "Solana is #1 in staking yield, chain revenue, and app revenue amongst all major blockchains. We believe creating a digital asset treasury will generate significant long-term value for Sharps Technology's shareholders."

    Solana's Compelling Growth Story with Attractive Yields

    • Solana currently offers ~7% staking yields, offering the highest yield output among the top five major blockchains.

    Solana is the Fastest and Most Used Blockchain in the World

    • 7,500+ new developers in 2024, making it the fastest growing blockchain ecosystem by developer count
    • $1.3 billion in revenue for apps on Solana year-to-date, the highest chain revenue and app revenue across all other blockchains in H1 20251
    • 8.9 billion in quarterly transactions2
    • $6 billion in daily trading volume, positioning Solana as one of the most liquid digital assets globally
    • 3.8 million average active daily wallets year-to-date3
    • The highest real transaction throughput (TPS) of any major blockchain, with low latency and consistent uptime

    Solana's Vision of a Unified Infrastructure Supported by TradFi Institutions

    • Powers stablecoins, money markets, and tokenized private funds for the world's largest institutions
    • Ability to support every exchange, custodian, platform, and onramp
    • Preferred platform for developers launching stablecoins, RWAs, payments, and Web3 apps

    Transaction Overview

    The offering consists of an over $400 million private investment in public equity transaction ("PIPE") for the purchase and sale of common stock (and/or pre-funded warrants to purchase shares of common stock) and stapled warrants to purchase shares of common stock at a purchase price of $6.50 per unit. The stapled warrants will be exercisable for a period of three years and have an exercise price equal to $9.75 (equal to 150% of the per unit price). Investors that intend to fund their purchase amount with locked and/or unlocked SOL in the offering will be issued and sold pre-funded warrants and stapled warrants, which warrants will become exercisable immediately following the Company's receipt of stockholder approval. The PIPE transaction is expected to close on or around August 28, 2025, subject to the satisfaction of customary closing conditions.

    Upon closing, the Company intends to use the net proceeds from the offering primarily to fund the acquisition of SOL in the open market and the establishment of the Company's SOL treasury operations, as well as for working capital and general corporate purposes. Sharps Technology has signed a non-binding letter of intent (LOI) with the Solana Foundation, a non-profit foundation based in Zug, Switzerland, dedicated to the decentralization, adoption, and security of the Solana ecosystem. Under the terms of the LOI, the Solana Foundation has committed, solely from the proceeds of a public offering by the Company, to selling $50 million of SOL at a 15% discount to a 30-day time-weighted average price, subject to certain conditions being met.

    About Alice Zhang

    Alice Zhang is the Co-Founder of Jambo, the first web3 phone with a built-in decentralized app store. She scaled distribution to 120+ countries, launching the largest mobile network on Solana. Ms. Zhang previously co-founded Avalon Capital, a global fund of funds specializing in digital assets and technology. She is an experienced investor and partner of many top digital asset industry leaders.

    About James Zhang

    James Zhang is the Chief Executive Officer and Co-Founder of Jambo, raising $40M+ from Paradigm, Pantera Capital, ParaFi Capital, Tiger Global, Coinbase, and others. He has been an active investor in the digital asset industry since 2017, including companies such as Coinbase, Bitmain, Messari, and others.

    Advisors

    Cantor Fitzgerald & Co. served as lead placement agent to the Company and Aegis Capital Corp. acted as co-placement agent to the Company.

    Madison Global Partners, LLC served as a financial advisor to the Company.

    Ellenoff Grossman and Schole LLP served as counsel to Sol Markets, the Company's strategic advisor.

    DLA Piper LLP (US) served as counsel to Cantor Fitzgerald & Co.

    Kaufman & Canoles, P.C. served as counsel to Aegis Capital Corp.

    Sichenzia Ross Ference Carmel LLP served as counsel to the Company.

    Securities Act Disclaimer

    The information provided in this press release is intended for informational purposes only and does not constitute investment advice, endorsement, analysis, or recommendations with respect to any financial instruments, investments, or issuers. Investment in cryptocurrency and DeFi projects involves substantial risk, including the risk of complete loss. This press release does not take into account the investment objectives, financial situation, or specific needs of any particular person and each individual is urged to consult their legal and financial advisors before making any investment decisions.

    Forward Looking Statements

    This press release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. This press release also includes express and implied forward-looking statements regarding the Company's current expectations, estimates, opinions and beliefs that are not historical facts. Such forward-looking statements may be identified by words such as "believes," "expects," "endeavors," "anticipates," "intends," "plans," "estimates," "projects," "should" and "objective" and the negative and variations of such words and similar words. These statements are made on the basis of current knowledge and, by their nature, involve numerous assumptions and uncertainties. Nothing set forth herein should be regarded as a representation, warranty or prediction that we will achieve or are likely to achieve any particular future result. Actual results may differ materially from those indicated in the forward-looking statements because the realization of those results is subject to many risks and uncertainties, including the risk that the proposed transactions described herein may not be completed in a timely manner or at all, the failure to realize the anticipated benefits of the private placement and related transactions, including the proposed digital asset treasury strategy, economic conditions, fluctuations in the market price of SOL, the impact on the Company's business of the evolving regulatory environment, the ability of the Company to execute on its digital asset treasury strategy, as well as other factors. Forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertake no duty to update such information except as required under applicable law.

    About Sharps Technology

    Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. Sharps Technology also offers products that are designed with specialized copolymer technology to support the pre-fillable syringe market segment. For additional information, please visit www.sharpstechnology.com.

    The Company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. Sharps Technology, following the closing of the PIPE and adoption of its digital asset treasury strategy will provide access to the Solana network, the fastest and most used blockchain in the world.

    Media Contact

    Prosek Partners for Sharps Technology

    [email protected] 

    1 Source: Artemis Analytics, Daily Transactions (Chain), as of Aug. 18, 2025

    2 Source: Blockworks, Solana: Onchain Activity (Q2)

    3 As of 8/18/2025

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sharps-technology-inc-announces-over-400-million-private-placement-seeking-to-establish-the-largest-solana-digital-asset-treasury-strategy-302537587.html

    SOURCE Sharps Technology Inc

    Get the next $STSS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STSS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STSS
    SEC Filings

    View All

    Sharps Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Sharps Technology Inc. (0001737995) (Filer)

    8/25/25 7:25:42 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Sharps Technology Inc.

    S-8 - Sharps Technology Inc. (0001737995) (Filer)

    8/22/25 5:20:57 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Sharps Technology Inc.

    10-Q - Sharps Technology Inc. (0001737995) (Filer)

    8/13/25 5:22:16 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sharps Technology, Inc. Announces over $400 Million Private Placement seeking to Establish the Largest Solana Digital Asset Treasury Strategy

    Investors include leading financial institutions and digital asset market leaders such as ParaFi, Pantera, Monarq, FalconX, Phoenix Capital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, CoinFund, Arrington Capital, Quantstamp, CoinList Alpha, Primitive Ventures, Avenir, Hypersphere, and more NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced the pricing of a private placement offering to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Solana is the

    8/25/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades

    Second commercial delivery underway as part of multi-year contract with leading U.S. healthcare partnerStrategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced an update on the execution of its first shipments under the previously announced $50 million SoloGard sales agreement, alongside a series of advanced manufacturing upgrades. Sharps has initiated

    6/18/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Life Sciences Investor Forum: Now Available for Online Viewing

    NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held June 11th and 12th are now available for online viewing. REGISTER AND VIEW PRESENTATIONS The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may downloadinvestor materials from the company's resource section. Select companies are accepting 1x1 management meeting requests through June 17. June 11th PresentationTicker(s)Nika Pharmaceuticals(OTCQB:NIKA)Tivic Health Systems Inc.(NASDAQ:TIVC)Ad

    6/13/25 8:35:00 AM ET
    $ATNM
    $BPTH
    $COCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties
    Medical/Nursing Services

    $STSS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Danner Paul K bought $100 worth of Series B Preferred Stock (5 units at $20.00) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    7/18/25 2:48:21 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Hayes Robert Michael bought $10,750 worth of shares (300,000 units at $0.04), increasing direct ownership by 297% to 400,882 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    4/1/25 5:24:02 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: Chief Executive Officer Hayes Robert Michael bought $10,072 worth of shares (5,000 units at $2.01), increasing direct ownership by 115% to 9,358 units (SEC Form 4)

    4/A - Sharps Technology Inc. (0001737995) (Issuer)

    12/6/24 5:15:10 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Danner Paul K bought $100 worth of Series B Preferred Stock (5 units at $20.00) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    7/18/25 2:48:21 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Large owner Bank Of America Corp /De/

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    5/6/25 4:27:50 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Hayes Robert Michael bought $10,750 worth of shares (300,000 units at $0.04), increasing direct ownership by 297% to 400,882 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    4/1/25 5:24:02 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Financials

    Live finance-specific insights

    View All

    Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (NASDAQ:SNGX) and Sharps Technology Inc. (NASDAQ:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Soligenix: https://www.redchip.com/assets/access/sngx_accessSharps Technology: https://www.redchip.com/assets/access/stss_accessIn an exclusive interview, Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix, appears on the RedChip Small Stocks Big Money™ show on B

    6/7/24 9:00:00 AM ET
    $SNGX
    $STSS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American Resources Corp. (NASDAQ:AREC) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Sharps Technology: https://www.redchip.com/assets/access/stss_accessReviva Pharmaceuticals: https://www.redchip.com/assets/access/rvph_accessAmerican Resources Corp: https://www.redchip.com/assets/access/arec_accessAbout The RedChip

    9/29/23 9:00:00 AM ET
    $AREC
    $RVPH
    $STSS
    Coal Mining
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RedChip Launches 'Small Stocks, Big Money' Podcast

    New podcast series shines a spotlight on undervalued small-cap and microcap stocksORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big Money."Hosted by RedChip CEO Dave Gentry and Associate Director Barrett Boone, the "Small Stocks, Big Money" podcast aims to offer a first-hand look at undiscovered small-cap and microcap stocks before they catch the attention of bigger Wall Street players. The series features in-depth interviews with executives from some of the top names in smaller cap stocks, providing list

    8/2/23 12:45:00 PM ET
    $BFRG
    $LTRN
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    $STSS
    Leadership Updates

    Live Leadership Updates

    View All

    Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

    NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ:STSS) (NASDAQ:STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is working to create new sales and distribution opportunities through the addition of new North American 3PL partnerships to expand its reach into the global healthcare market. These additional third-party logistics partnerships, along with a developing alliance with Roncadelle Operations, a driving force in the development of safe, novel medical drug delivery devices, would combine the strengths and capabilities of the two companies to develop, market and distribute unique dru

    2/16/24 2:42:54 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales

    Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the market Product qualification and sales initiatives underway as company prepares for U.S. commercial operations NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, is pleased to announce the appointment of Ben Scheu as Senior Director of Sales to lead commercial operations as the Company prepares to launch products to the market.

    7/12/23 8:33:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Justin Page as Vice President of Technical Operations

    NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company", "Sharps") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as Vice President of Technical Operations. In his role, Mr. Page will be responsible for managing all aspects of Sharps' engineering operations. His primary focus will be to provide the leadership and technical expertise to support the prefillable syringe collaboration with Nephron Pharmaceuticals at the InjectEZ facility. These efforts will include the support for the injection molding of the specialty components and the high speed assembl

    2/9/23 9:21:23 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    11/13/24 4:50:17 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    10/9/24 9:01:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Sharps Technology Inc.

    SC 13G - Sharps Technology Inc. (0001737995) (Subject)

    2/14/24 11:14:11 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care